Herpes simplex virus partially liquefies the tightly packed, gel-like interior of human cell nuclei to copy itself faster, a new study shows. The research centers on how the nucleus of each human cell ...

Pritelivir, an investigational antiviral drug for herpes simplex virus, demonstrated “superior efficacy” in healing lesions ...

Ongoing research aims to confirm the mechanism by which ICP4 fluidizes the nucleus, which could indicate specific targets to counter viral replication.

Pritelivir, an investigational antiviral for herpes simplex virus, demonstrated strong efficacy in a phase 3 trial, with 62.7% of immunocompromised patients achieving lesion healing. The ...

The incidence of neonatal herpes simplex virus (HSV) infections in the UK and Ireland increased dramatically over 15 years, and outcomes remained poor, with mortality and long-term neurologic ...

For many years, scientists have known that the herpes simplex virus-1 (HSV-1), which causes cold sores, can take up residence in parts of neurons in the peripheral nervous system. Stress can even ...

A modified herpes virus boosted immune T cell infiltration in glioblastoma tumors and was associated with improved survival.

According to a new study, the herpes simplex virus partially liquefies the densely packed, gel-like core of human cell nuclei ...